Equity (Tables)

6 Months Ended

Jun. 30, 2022

Equity [Abstract]

Schedule of warrants outstanding

	Shares of Common Stock Issuable from Warrants Outstanding as of				Weighted
	June 30,		December 31,		Average
Description	2022		2021		Exercise Price		Expiration
Series F		-		7,246	$	3.45		February 23, 2022
Series G		460,250		460,250	$	2.68		July 21, 2022
Series H		910,000		910,000	$	2.75		October 16, 2022
Series I		10,335,000		10,335,000	$	2.00		November 26, 2025
Total		11,705,250		11,712,496

Schedule of stock option activity

	Number of Options			Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value ($)
Outstanding at December 31, 2021		3,139,999			2.17
Granted		-			-
Forfeited		(115,000	)		2.23
Outstanding at June 30, 2022		3,024,999			2.17
Outstanding at June 30, 2022		3,024,999			2.17		4.04 years		-
Vested and exercisable at June 30, 2022		2,674,999			2.03		4.05 years		-

Schedule of consolidated statement of operations

	Three Months Ended June 30,					Six Months Ended June 30,
	2022		2021			2022		2021
Research and development	$	217,500	$	228,625		$	435,000	$	507,438
General and administrative		-		(29,026	)		5,500		(1,182,601	)
Total	$	217,500	$	199,599		$	440,500	$	(675,163	)